{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:15:02Z","timestamp":1790540102596,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s12325-009-0037-2","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T23:31:09Z","timestamp":1245713469000},"page":"651-659","source":"Crossref","is-referenced-by-count":75,"title":["Efficacy of topical cyclosporine for the treatment of ocular rosacea"],"prefix":"10.1007","volume":"26","author":[{"given":"Barry A.","family":"Schechter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","volume":"22","author":"V.C. Ghanem","year":"2003","unstructured":"Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22:230\u2013233.","journal-title":"Cornea"},{"key":"37_CR2","first-page":"11","volume":"62","author":"V.J. Marmion","year":"1969","unstructured":"Marmion VJ. Tetracyclines in the treatment of ocular rosacea. Proc R Soc Med. 1969;62:11\u201312.","journal-title":"Proc R Soc Med"},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0161-6420(97)30015-3","volume":"104","author":"E.K. Akpek","year":"1997","unstructured":"Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104:1863\u20131867.","journal-title":"Ophthalmology"},{"key":"37_CR4","first-page":"334","volume-title":"Ocular Infection and Immunity","author":"R.W. Bowman","year":"1996","unstructured":"Bowman RW, McCulley JP, Jester JV. Meibomian gland dysfunction and rosacea. In: Pepose J, Holland G, Wilhelmus K, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book; 1996:334\u2013343."},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/112067210301300404","volume":"13","author":"A.G. Kocak-Altintas","year":"2003","unstructured":"Kocak-Altintas AG, Kocak-Midillioglu I, Gul U, et al. Impression cytology and ocular characteristics in ocular rosacea. Eur J Ophthalmol. 2003;13:351\u2013359.","journal-title":"Eur J Ophthalmol"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","volume":"104","author":"K. Barton","year":"1997","unstructured":"Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868\u20131874.","journal-title":"Ophthalmology"},{"key":"37_CR7","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ajo.2004.12.075","volume":"139","author":"A.J. Bron","year":"2005","unstructured":"Bron AJ. Diagnosis of meibomian gland disease and MKC: what is really meant by meibomian inflammation? Am J Ophthalmol. 2005;139:S23\u2013S24.","journal-title":"Am J Ophthalmol"},{"key":"37_CR8","first-page":"336","volume":"106","author":"M. Macsai","year":"2008","unstructured":"Macsai M. The role of Omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:336\u2013356.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","volume":"90","author":"T. Jansen","year":"1997","unstructured":"Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144\u2013150.","journal-title":"J R Soc Med"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"46","author":"J. Wilken","year":"2002","unstructured":"Wilken J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584\u2013587.","journal-title":"J Am Acad Dermatol"},{"key":"37_CR11","unstructured":"Randleman JB, Loft E, Song CD. Ocular rosacea. Available at: http:\/\/www.emedicine.com\/oph\/topic115.htm . Accessed Nov. 7, 2006."},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","volume":"54","author":"E. Donnenfeld","year":"2009","unstructured":"Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: Pharmacology and clinical uses. Surv Ophthalmol. 2009;54:321\u2013338.","journal-title":"Surv Ophthalmol"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K. Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107:631\u2013963. Erratum in: Ophthalmology. 2000;107:1220.","journal-title":"Ophthalmology"},{"key":"37_CR14","unstructured":"Restasis [package insert]. CA: Allergan Inc.; 2004."},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","volume":"118","author":"K.S. Kunert","year":"2000","unstructured":"Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118:1489\u20131496.","journal-title":"Arch Ophthalmol"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2005.08.035","volume":"141","author":"S. Doan","year":"2006","unstructured":"Doan S, Gabison E, Gatinel D, Duong M-H, Abitbol O, Hoang-Xuan T. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular kerato-conjunctivitis. Am J Ophthalmol. 2006;141:62\u201366.","journal-title":"Am J Ophthalmol"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"R.M. Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615\u2013621.","journal-title":"Arch Ophthalmol"},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"A.J. Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640\u2013650.","journal-title":"Cornea"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","volume":"40","author":"P.J. Driver","year":"1996","unstructured":"Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343\u2013367.","journal-title":"Surv Ophthalmol"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199503000-00005","volume":"14","author":"N. Zengin","year":"1995","unstructured":"Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14:144\u2013146.","journal-title":"Cornea"},{"key":"37_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","volume":"19","author":"K. Turner","year":"2000","unstructured":"Turner K, Pflugfelder SC, Ji Z, et al. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000;19:492\u2013496.","journal-title":"Cornea"},{"key":"37_CR22","unstructured":"Perry HD, Wittpenn JR, D\u2019Aversa G, Donnenfeld ED. Topical cyclosporine 0.05% for the treatment of chronic, active ocular rosacea. Poster presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 3, 2005; Ft. Lauderdale, Florida, USA."},{"key":"37_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","volume":"25","author":"H.D. Perry","year":"2006","unstructured":"Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25:171\u2013175.","journal-title":"Cornea"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0037-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:55Z","timestamp":1559447755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0037-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0037-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718430989.793495899","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}